This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kobayashi, H. Articles by Sugino, D. Search for Related Content PubMed PubMed Citation Articles by Kobayashi, H. Articles by Sugino, D.

Inhibition of Tumor Cell Invasion through Matrigel by a Peptide Derived from the Domain II Region in Urinary Trypsin Inhibition

Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Handacho 3600, Hamamatsu Shizuoka 431-31 [H. K., J. G., N. K., Y. H., T. T.], and Nissin Food Products Co., Ltd., Nissin Central Research Institute, Nojicho 2247, Kusatsu, Shiga [D. S.], 525, Japan

Urinary trypsin inhibitor (UTI) has a multipotent inhibitory effect on proteases such as trypsin, chymotrypsin, plasmin, human leukocyte elastase, or hyaluronidase. UTI can bind easily to its receptors on various types of tumor cells (human ovarian cancer HOC-I cells, human choriocarcinoma SMT-cc1 cells, and murine Lewis lung carcinoma 3LL cells). Our results show that the UTI receptors of some tumor cells have a possible role in modulating plasmin activity on the cell surface and prevention of tumor cell invasion and metastasis (H. Kobayashi et al., J. Biol. Chem., 269: 20642–20647, 1994). UTI interacts with tumor cells as a negative modulator of the invasive cells. We investigated whether this effect may be mediated by UTI binding to the cell surface receptors. In addition, the role of peptide sequences from each UTI domain and their interaction with tumor cells were investigated. UTI derivatized with biotin or FITC was taken up by tumor cells in a dose-dependent manner. This cell association was inhibited with a monoclonal antibody D1, which specifically recognizes NH₂ terminus (domain I) of UTI. The binding was inhibited by fluid phase UTI, but not HI-8, COOH terminus (domain II) of UTI, suggesting that UTI binds to cells through a site in the UTI domain I. Furthermore, we found that UTI, HI-8 and a number of peptides containing Arg-Gly-Pro-Cys-Arg-Ala-Phe-Ile promoted the inhibition of tumor cell invasion. This site corresponds to the plasmin-inhibiting domain within HI-8. The possibility that UTI binding to tumor cells might be involved in the prevention of tumor cell invasion in vitro was excluded since HI-8, lacking domain I, promotes the inhibition of tumor cell invasion with essentially the same affinity as UTI. All these data allow us to conclude that inhibition of tumor cell invasion is mediated by domain II, which possesses anti-plasmin activity.

¹ To whom requests for reprints should be addressed.

Received 12/30/94. Accepted 3/17/95.

This article has been cited by other articles:

				M. Suzuki, H. Kobayashi, M. Fujie, T. Nishida, M. Takigawa, N. Kanayama, and T. Terao Kunitz-type Protease Inhibitor Bikunin Disrupts Phorbol Ester-induced Oligomerization of CD44 Variant Isoforms Containing Epitope v9 and Subsequently Suppresses Expression of Urokinase-type Plasminogen Activator in Human Chondrosarcoma Cells J. Biol. Chem., March 1, 2002; 277(10): 8022 - 8032. [Abstract] [Full Text] [PDF]

				H. Kobayashi, J. Gotoh, Y. Hirashima, and T. Terao Inter-alpha-trypsin Inhibitor Bound to Tumor Cells Is Cleaved into the Heavy Chains and the Light Chain on the Cell Surface J. Biol. Chem., May 10, 1996; 271(19): 11362 - 11367. [Abstract] [Full Text] [PDF]

				H. Kobayashi, M. Suzuki, Y. Tanaka, Y. Hirashima, and T. Terao Suppression of Urokinase Expression and Invasiveness by Urinary Trypsin Inhibitor Is Mediated through Inhibition of Protein Kinase C- and MEK/ERK/c-Jun-dependent Signaling Pathways J. Biol. Chem., January 12, 2001; 276(3): 2015 - 2022. [Abstract] [Full Text] [PDF]

				Y. Hirashima, H. Kobayashi, M. Suzuki, Y. Tanaka, N. Kanayama, M. Fujie, T. Nishida, M. Takigawa, and T. Terao Characterization of Binding Properties of Urinary Trypsin Inhibitor to Cell-associated Binding Sites on Human Chondrosarcoma Cell Line HCS-2/8 J. Biol. Chem., April 20, 2001; 276(17): 13650 - 13656. [Abstract] [Full Text] [PDF]